News & Updates

Treatment with budesonide once daily effectively maintains endoscopic and histologic remission in most patients with eosinophilic esophagitis (EoE), which is similar to reported outcomes with twice daily dosing, according to a study.

For patients with unexplained acute recurrent pancreatitis and pancreas divisum, performing endoscopic retrograde cholangiopancreatography (ERCP) with minor papillotomy does not appear to lower the risk of another episode of acute pancreatitis or related sequelae, according to a study.

Ramadan fasting may induce dyspeptic symptoms, especially in women and older adults, suggests a study. Medication timing and dietary changes during fasting appear to influence such risk.

Patients with inflammatory bowel disease (IBD) face an increased risk of colorectal cancer (CRC), and this association is especially pronounced for those who have primary sclerosing cholangitis (PSC), according to a study.

The T-type calcium channel blocker ethosuximide has shown limited benefit in the treatment of irritable bowel syndrome (IBS)-related abdominal pain in a proof-of-concept study.

Treatment with simvastatin does not appear to reduce the recurrence of pancreatitis when compared with placebo, according to interim data from a study.

Individuals with higher scores in the dietary index for gut microbiota (DI-GM) appear to enjoy a reduced risk of hypertension, with the greatest benefit seen among nonsmokers and those with partners, reports a recent study.

Exposure to acid-suppressive medications during pregnancy does not appear to contribute to the risk of neuropsychiatric disorders in children, according to a retrospective study.

Dietary interventions continue to provide benefits in the management of chronic liver diseases and serve as a valuable addition to pharmacotherapy options available, reports a study.

A recent study has demonstrated the long-term safety of mirikizumab in patients with moderate to severe active ulcerative colitis (UC), with no new significant safety concerns.